Evidence map›Paper›PMID 39865800›Full record

ArticleEuropean psychiatry : the journal of the Association of European Psychiatrists2025

Associations between IL-6 and trajectories of depressive symptoms across the life course: Evidence from ALSPAC and UK Biobank cohorts.

Amelia J Edmondson-Stait, Ella Davyson, Xueyi Shen, Mark James Adams, Golam M Khandaker, Veronique E Miron, Andrew M McIntosh, Stephen M Lawrie, Alex S F Kwong, Heather C Whalley

Abstract read
In one paragraph

Article in European psychiatry : the journal of the Association of European Psychiatrists, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Best practices for using biological data in psychological research.Journal of mood and anxiety disorders · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amelia J Edmondson-StaitTranslational Neuroscience PhD Programme, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0003-1456-5128
Ella DavysonCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-7313-0530
Xueyi ShenCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-0538-4774
Mark James AdamsCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-3599-6018
Golam M KhandakerMRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Veronique E MironBARLO Multiple Sclerosis Centre, Keenan Research Centre for Biomedical Science at St. Michael's Hospital, Toronto, ON, Canada.
Andrew M McIntoshCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-0198-4588
Stephen M LawrieCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-2444-5675
Alex S F KwongCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0003-1953-2771
Heather C WhalleyCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-4505-8869

Funding

Medical Research Council MC_UU_00032/6Medical Research Council MR/S037675/1Medical Research Council MR/W014416/1Wellcome Trust 201486/Z/16/Z
6 · The paper itself

Abstract

backgroundPeripheral inflammatory markers, including serum interleukin 6 (IL-6), are associated with depression, but less is known about how these markers associate with depression at different stages of the life course.

methodsWe examined the associations between serum IL-6 levels at baseline and subsequent depression symptom trajectories in two longitudinal cohorts: ALSPAC (age 10-28 years;

resultsHigher baseline IL-6 was associated with worse depression symptom trajectories in both cohorts (largest effect size: 0.046 [ALSPAC, age 16 years]). These associations were stronger in the younger ALSPAC cohort, where additionally higher IL-6 levels at age 9 years was associated with worse depression symptoms trajectories in females compared to males. Weaker sex differences were observed in the older cohort, UK Biobank. However, statistically significant associations (pFDR <0.05) were of smaller effect sizes, typical of large cohort studies.

conclusionsThese findings suggest that systemic inflammation may influence the severity and course of depressive symptoms across the life course, which is apparent regardless of age and differences in measures and number of time points between these large, population-based cohorts.

Indexed as

DepressionInterleukin-6AdolescentAdultAgedAged, 80 and overBiological Specimen BanksBiomarkersChildFemaleHumansLongitudinal StudiesMaleMiddle AgedSex FactorsUK BiobankBiomarkersIL6 protein, humanInterleukin-6ALSPACdepressioninflammationtrajectoriesUK Biobank

Identifiers

PMID39865800
PMCPMC11883784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.